Risks during pregnancy in women with epilepsy
- PMID: 26318521
- PMCID: PMC6350524
- DOI: 10.1016/S0140-6736(15)00047-1
Risks during pregnancy in women with epilepsy
Comment on
-
Epilepsy in pregnancy and reproductive outcomes: a systematic review and meta-analysis.Lancet. 2015 Nov 7;386(10006):1845-52. doi: 10.1016/S0140-6736(15)00045-8. Epub 2015 Aug 25. Lancet. 2015. PMID: 26318519
References
-
- Tomson T, Battino D. Teratogenic effects of antiepileptic drugs. Lancet Neurol 2012; 11: 803–13. - PubMed
-
- Harden CL, Meador KJ, Pennell PB, et al., American Academy of Neurology, American Epilepsy Society. Management issues for women with epilepsy—focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: report of the quality standards subcommittee and therapeutics and technology subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 2009; 50: 1237–46. - PubMed
-
- Hernandez-Diaz S, Smith CR, Shen A, et al., for the North American AED Pregnancy Registry. Comparative safety of antiepileptic drugs during pregnancy. Neurology 2012; 78: 1692–99. - PubMed
-
- Tomson T, Battino D, Bonizzoni E, et al., for the EURAP study group. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011; 10: 609–17 - PubMed